Magazine article Drug Topics

Generic Stage Set to Feature New Cast of Characters

Magazine article Drug Topics

Generic Stage Set to Feature New Cast of Characters

Article excerpt

Get ready for some top-level executive shuffling in the generic industry this year. Not only have two of the three generic trade associations made plans to merge and to name a new leader for the unified organization, but also a new director is expected soon at the Office of Generic Drugs (OGD) within the Food & Drug Administration.

This is the third time in eight years that the three generic associations have attempted to merge. This time around, the boards of the Generic Pharmaceutical Industry Association (GPIA) and the National Pharmaceutical Alliance (NPA) have unanimously agreed to merge. The deal is still subject to member approval. The third generic association-The National Association of Pharmaceutical Manufacturers (NAPM)opted to remain independent because it feels its members would be underrepresented on the new combined board.

If the merger of GPIA and NPA goes through, the new group will be based in Washington, D.C., and will represent more than 90% of all generic prescriptions written and refilled. This makes it potentially a stronger advocate for generic drugs than any of the three associations on its own.

For now, both the new entity and NAPM say they're planning to step up their campaigns to sell generics to policymakers, consumers, the media, and others. NAPM, which had recently produced a televised documentary on generics, also reported that it intends to schedule meetings with the American Medical Association, the American Academy of Pediatrics, and other national groups to dispel the misconceptions many doctors still have about generics. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.